首页|期刊导航|BIOCELL|YOD1 Stabilizes RIPK1 via Deubiquitination to Activate NF-κB and Promote Cardiomyocyte H/R Injury

YOD1 Stabilizes RIPK1 via Deubiquitination to Activate NF-κB and Promote Cardiomyocyte H/R InjuryOA

中文摘要

Background:Myocardial ischemia-reperfusion(I/R)injury represents a severe pathological process in cardiovascular diseases.This study aims to elucidate the mechanism of the yeast ovarian tumor(OTU)domain-containing protein 1(YOD1)in cardiomyocyte injury.Methods:A hypoxia/reoxygenation(H/R)model was established using human AC16 cells to simulate I/R injury in vitro.Reverse transcription quantitative PCR(RT-qPCR)and western blotting were used to detect gene and protein expression.Cellular functions were evaluated using Cell Counting Kit-8(CCK-8),lactate dehydrogenase(LDH),enzyme-linked immunosorbent assay(ELISA),flow cytometry,and biochemical kits.Protein interaction was validated through co-immunoprecipitation(Co-IP),ubiquitination assays,and cycloheximide(CHX)chase experiments.Results:YOD1 was up-regulated in H/R-induced AC16 cells(p<0.01).H/R decreased cell viability(p<0.001),superoxide dismutase(SOD)(p<0.001),and glutathione peroxidase 4(GPX4)(p<0.001)and increased LDH(p<0.001),interleukin-6(IL-6)(p<0.001),tumor necrosis factor-alpha(TNF-α)(p<0.001),reactive oxygen species(ROS)(p<0.001),malondialdehyde(MDA)(p<0.001),and Fe^(2+)(p<0.001);these effects were alleviated by YOD1 knockdown(p<0.01).YOD1 knockdown(p<0.001)also reversed H/R-increased receptor-interacting serine/threonine kinase 1(RIPK1)protein levels(p<0.001)and p-p65/p65(p<0.001)and p-nuclear factor-kappa-B inhibitor alpha(p-IκBα)/IκBα(p<0.001)ratios.RIPK1 overexpression reversed the protective effects of YOD1 knockdown via activating the nuclear factor-kappa-B(NF-κB)pathway(p<0.01).Mechanistically,YOD1 interacted with RIPK1 and inhibited its K63-linked ubiquitination degradation(p<0.01).These statistical significances support the clinical potential of targeting YOD1 to mitigate inflammation,oxidative stress,and ferroptosis-related changes in myocardial I/R injury.Conclusion:YOD1 stabilizes RIPK1 via K63-linked ubiquitination to activate the NF-κB pathway,exacerbating inflammation,oxidative stress,and ferroptosis-related changes in H/R-induced cardiomyocytes.YOD1 may represent a potential therapeutic target for myocardial I/R injury,though further in vivo and clinical validation is required.

Liangliang Liu;Linjun Wang;Xin Song;Zhen Liu

Department of Cardiology,Lianyungang Hospital of Traditional Chinese Medicine,Lianyungang,ChinaDepartment of Cardiology,Lianyungang Hospital of Traditional Chinese Medicine,Lianyungang,ChinaDepartment of Cardiology,Lianyungang Hospital of Traditional Chinese Medicine,Lianyungang,ChinaDepartment of Cardiology,Lianyungang Hospital of Traditional Chinese Medicine,Lianyungang,China

医药卫生

Yeast ovarian tumor domain-containing protein 1receptor-interacting serine/threonine kinase 1myocardial ischemia-reperfusion injuryubiquitinationferroptosisnuclear factor-kappa-B pathway

《BIOCELL》 2026 (9)

P.179-191,13

10.32604/biocell.2026.080414

评论